• Molecular NameLumiracoxib
  • SynonymCOX 189; lumiracoxib
  • Weight293.725
  • Drugbank_IDDB01283
  • ACS_NO220991-20-8
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)4.35
  • pkaN/A
  • LogD (pH=7, predicted)1.73
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-1.82
  • LogSw (predicted, AB/LogsW2.0)0.03
  • Sw (mg/ml) (predicted, ACD/Labs)0.02
  • No.of HBond Donors2
  • No.of HBond Acceptors3
  • No.of Rotatable Bonds4
  • TPSA49.33
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA COX-2 selective inhibitor non-steroidal anti-inflammatory drug
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability74.0
  • Protein binding98.0
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmHepatic oxidation and hydroxylation (CYP2C9)
  • Half life4 h
  • ExcretionRenal and fecal
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A